Valuation: PharmaEssentia Corporation

Market Cap 485B 15.17B 13.48B 12.6B 11.48B 21.62B 1,461B 21.92B 152B 59.02B 744B 56.96B 55.73B 2,390B P/E 2026 *
43.3x
P/E 2027 * 27.2x
Enterprise Value 459B 14.35B 12.75B 11.92B 10.86B 20.45B 1,382B 20.74B 144B 55.84B 704B 53.89B 52.72B 2,261B EV / Sales 2026 *
16x
EV / Sales 2027 * 10.9x
Free-Float
77.94%
Yield 2026 *
0.34%
Yield 2027 * 0.2%
1 day-3.70%
1 week+1.30%
Current month-3.70%
1 month-10.69%
3 months-4.57%
6 months+104.39%
Current year+176.14%
1 week 1,160
Extreme 1160
1,240
1 month 1,125
Extreme 1125
1,450
Current year 423.7
Extreme 423.699083
1,645
1 year 407.92
Extreme 407.923053
1,645
3 years 228.27
Extreme 228.269713
1,645
5 years 56.05
Extreme 56.051993
1,645
10 years 43.54
Extreme 43.541837
1,645
Manager TitleAgeSince
Chief Executive Officer - 31/12/2016
Director of Finance/CFO - 13/10/2015
President - 24/06/2015
Director TitleAgeSince
Director/Board Member - 08/05/2000
Chairman - 23/09/2012
Director/Board Member - 28/05/2015
Change 5-day change 1-year change 3-year change Capi.($)
-3.70%+1.30%+132.17%+328.65% 15.17B
+4.16%+3.04%+49.37%+94.17% 74.41B
-1.21%-1.63%+24.31%+78.03% 59.26B
+1.21%-0.53%+4.39%+34.65% 47.14B
-3.02%-5.20%+27.94%+32.51% 42.91B
+0.31%+3.02%+348.95%+643.82% 44.13B
-1.96%-0.33%+7.04%+99.46% 40.79B
+3.32%+3.49%+10.10%+51.23% 30.77B
-2.68%+2.92%+29.63%+22.72% 29.31B
-4.86%-10.66%-26.27%+330.06% 23.71B
Average -0.84%-0.51%+60.76%+171.53% 40.76B
Weighted average by Cap. -0.12%-0.32%+60.76%+152.56%

Financials

2026 *2027 *
Net sales 28.58B 894M 794M 743M 677M 1.27B 86.11B 1.29B 8.99B 3.48B 43.86B 3.36B 3.29B 141B 41.51B 1.3B 1.15B 1.08B 983M 1.85B 125B 1.88B 13.05B 5.05B 63.69B 4.88B 4.77B 205B
Net income 10.93B 342M 304M 284M 259M 487M 32.92B 494M 3.44B 1.33B 16.76B 1.28B 1.26B 53.85B 18.25B 571M 507M 474M 432M 814M 54.98B 825M 5.74B 2.22B 28B 2.14B 2.1B 89.94B
Net Debt -26.15B -818M -727M -680M -619M -1.17B -78.77B -1.18B -8.22B -3.18B -40.11B -3.07B -3B -129B -34.24B -1.07B -952M -890M -811M -1.53B -103B -1.55B -10.77B -4.17B -52.54B -4.02B -3.94B -169B
Logo PharmaEssentia Corporation
PHARMAESSENTIA CORPORATION is a Taiwan-based company primarily engaged in the research and development, clinical trials, manufacturing, sale, and marketing of innovative biotechnology drugs. It also oversees registration and marketing authorization applications based on product development progress. The Company focuses on hematology and oncology, utilizing the PEGylation technology platform for drug candidate design and development. The Company’s proprietary product, Ropeg, is used to treat polycythemia vera (PV), primarily sold in the United States.
Employees
131
Date Price Change Volume
01/10/26 NT$1,170.00 -3.70% 2,506,975
30/09/26 NT$1,215.00 +1.67% 1,685,359
29/09/26 NT$1,195.00 +3.46% 2,229,766
24/09/26 NT$1,155.00 -1.70% 1,460,375
23/09/26 NT$1,175.00 +1.29% 2,241,457
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
1,170.00TWD
Average target price
1,482.61TWD
Spread / Average Target
+26.72%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 6446 Stock